The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.

Latest News

Breast MRI Quantification of Intra-Tumoral Heterogeneity May Help Predict Response to Neoadjuvant Chemotherapy
Breast MRI Quantification of Intra-Tumoral Heterogeneity May Help Predict Response to Neoadjuvant Chemotherapy

April 16th 2025

An emerging nomogram model for intra-tumoral heterogeneity quantification with breast MRI demonstrated an average 85 percent sensitivity in external validation testing for predicting pathologic complete response to neoadjuvant chemotherapy for breast cancer.

New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection

April 15th 2025

Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?

April 10th 2025

Imaging-Based Treatment Modifications Only Used in 15 Percent of Neoadjuvant Systemic Therapy Trials for Breast Cancer
Imaging-Based Treatment Modifications Only Used in 15 Percent of Neoadjuvant Systemic Therapy Trials for Breast Cancer

April 9th 2025

MRI Study Suggests Shape of White Matter Hyperintensities May Be Predictive of Cognitive Decline
MRI Study Suggests Shape of White Matter Hyperintensities May Be Predictive of Cognitive Decline

April 7th 2025

Latest CME Events & Activities

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

View More

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Register Now!

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

View More

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 12-14, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

43rd Annual Miami Breast Cancer Conference®

March 5-8, 2026

Register Now!

19th Annual New York GU Cancers Congress™

March 13-14, 2026

Register Now!

Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies

View More

(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice

View More

More News

© 2025 MJH Life Sciences

All rights reserved.